After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Day One Biopharmaceuticals Inc is $637.57M. A total of 1.14 million shares were traded on the day, compared to an average of 1.41M shares.
In the most recent transaction, Merendino Lauren sold 3,927 shares of DAWN for 6.26 per share on May 16 ’25. After the transaction, the Chief Commercial Officer now owns 35,161 company shares. In a previous transaction on May 16 ’25, Dubow Adam sold 4,552 shares at 6.26 per share. DAWN shares that GENERAL COUNSEL owns now total 47,136.
Among the insiders who sold shares, York Charles N II disposed of 4,282 shares on May 16 ’25 at a per-share price of $6.26. This resulted in the COO, CFO AND SECRETARY holding 265,231 shares of DAWN after the transaction. In another insider transaction, Bender Jeremy sold 13,964 shares at $6.26 per share on May 16 ’25. Company shares held by the CHIEF EXECUTIVE OFFICER now total 145,737.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, DAWN has a high of $16.76 and a low of $6.08.
As of this writing, DAWN has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.25 per share and a lower estimate of -$0.4.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DAWN’s latest balance sheet shows that the firm has $284.31M in Cash & Short Term Investments as of fiscal 2021. There were $220.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $4.73, while its Total Shareholder’s Equity was $281.15M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
